rs377063950
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BP4_Strong
The NM_001267550.2(TTN):āc.12889T>Gā(p.Cys4297Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000057 in 1,613,594 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. C4297C) has been classified as Likely benign.
Frequency
Consequence
NM_001267550.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TTN | NM_001267550.2 | c.12889T>G | p.Cys4297Gly | missense_variant | Exon 48 of 363 | ENST00000589042.5 | NP_001254479.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TTN | ENST00000589042.5 | c.12889T>G | p.Cys4297Gly | missense_variant | Exon 48 of 363 | 5 | NM_001267550.2 | ENSP00000467141.1 |
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152118Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000113 AC: 28AN: 248276Hom.: 0 AF XY: 0.0000594 AC XY: 8AN XY: 134670
GnomAD4 exome AF: 0.0000506 AC: 74AN: 1461476Hom.: 0 Cov.: 31 AF XY: 0.0000536 AC XY: 39AN XY: 727018
GnomAD4 genome AF: 0.000118 AC: 18AN: 152118Hom.: 0 Cov.: 32 AF XY: 0.000188 AC XY: 14AN XY: 74302
ClinVar
Submissions by phenotype
not provided Uncertain:2
The TTN p.Cys4059Gly variant was not identified in the literature nor was it identified in LOVD 3.0. The variant was identified in dbSNP (ID: rs377063950) and ClinVar (classified as uncertain significance by Laboratory for Molecular Medicine and as likely benign by Invitae). The variant was identified in control databases in 28 of 248276 chromosomes at a frequency of 0.000113 (Genome Aggregation Database March 6, 2019, v2.1.1). The variant was observed in the following populations: Ashkenazi Jewish in 20 of 10040 chromosomes (freq: 0.001992), Latino in 4 of 34446 chromosomes (freq: 0.000116) and European (non-Finnish) in 4 of 112328 chromosomes (freq: 0.000036), but was not observed in the African, East Asian, European (Finnish), Other, or South Asian populations. The p.Cys4059 residue has limited species conservation data and computational analyses (PolyPhen-2, BLOSUM, MutationTaster) provide inconsistent predictions regarding the impact to the protein. The variant occurs outside of the splicing consensus sequence and three of four in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a greater than 10% difference in splicing; this is not very predictive of pathogenicity. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. -
The TTN NM_001267550.2: c.12889T>G; p.Cys4297Gly variant (rs377063950; ClinVar Variation ID: 166235) is rare in the general population (<0.2% allele frequency in the Genome Aggregation Database) and has not been reported in the medical literature in association with dilated cardiomyopathy (DCM) or other TTN-related disease. The clinical relevance of rare missense variants in this gene, which are identified on average once per individual sequenced in affected populations (Herman 2012), is not well understood. Yet, evidence suggests that the vast majority of such missense variants do not contribute to the clinical outcome of DCM (Begay 2015). Thus, the clinical significance of the p.Cys4297Gly variant cannot be determined with certainty. -
not specified Uncertain:1
The Cys4059Gly variant in TTN has not been previously reported in individuals wi th cardiomyopathy, but has been identified in 1/8244 European American chromosom es by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS/; dbS NP rs377063950). Computational analyses are limited or unavailable for this vari ant. Additional studies are need to fully assess the clinical significance of th is variant. -
Cardiovascular phenotype Uncertain:1
The p.C3934G variant (also known as c.11800T>G), located in coding exon 44 of the TTN gene, results from a T to G substitution at nucleotide position 11800. The cysteine at codon 3934 is replaced by glycine, an amino acid with highly dissimilar properties. This amino acid position is not well conserved in available vertebrate species, and glycine is the reference amino acid in other vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Autosomal recessive limb-girdle muscular dystrophy type 2J;C1858763:Dilated cardiomyopathy 1G Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at